Jubilant Pharmova Ltd consolidated Q2FY22 net profit at Rs 142 84 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma to Remain Integral to Group After Reorganisation: S&P
moneylife.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneylife.in Daily Mail and Mail on Sunday newspapers.
Jubilant Pharma s Ratings Unaffected by Proposed Reorganisation: Fitch
moneylife.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneylife.in Daily Mail and Mail on Sunday newspapers.
Motilal Oswal has buy call on Jubilant Pharmova Ltd. with a target price of Rs 920. The current market price of Jubilant Pharmova Ltd. is Rs 718.15. Time period given by analyst is one year when Jubilant Pharmova Ltd. price can reach defined target.
Jubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 11241.27 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 1586.47 Crore, down -10.62 % from last quarter Total Income of Rs 1774.93 Crore and down -34.19 % from last year same quarter Total Income of Rs 2410.85 Crore. Company reported net profit after tax of Rs 199.30 Crore in latest quarter.